ez Adelaide egyszerűen median overall survival greater than median follow up Telepesek Mérges lesz Híres ember
The Treatment Landscape of Metastatic Urothelial Carcinoma: Second-Line Systemic Therapy
Interpreting Survival Probability in Relation to 'Number at Risk' and Median Follow-Up Times - interpret - Datamethods Discussion Forum
Laying the Foundation Towards Long-Term Survival in Patients with High-Risk Acute Myeloid Leukaemia - European Medical Journal
Impact of weight loss on survival after chemoradiation for locally advanced head and neck Cancer: secondary results of a randomized phase III trial (SAKK 10/94) | Radiation Oncology | Full Text
Let's Flip: An Approach to Understand Median Follow-up by the Reverse Kaplan-Meier Estimator from a Statistical Programmer's
Re-irradiation combined with bevacizumab for recurrent glioblastoma beyond bevacizumab failure: survival outcomes and prognostic factors | Scientific Reports
Society of Urologic Oncology - MANAGEMENT AND OUTCOMES OF PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER: EVOLUTION OF THE UNIVERSITY OF SOUTHERN CALIFORNIA EXPERIENCE OVER 3,347 CASES
a Kaplan–Meier survival curve with a median follow-up time of... | Download Scientific Diagram
Survival (time to event) data: median survival times | The BMJ
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
Survival Analysis in R
primed.info
Survival Analysis
Survival Analysis in R
GraphPad Prism 10 Statistics Guide - Determining the median followup time
Finding median survival time from survival function - Cross Validated
Let's Flip: An Approach to Understand Median Follow-up by the Reverse Kaplan-Meier Estimator from a Statistical Programmer's
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry - The Lancet Regional Health – Europe
Kaplan-Meier survival analysis
How Median Follow-up Time Informs Survival Outcomes: Lessons from a Trial of Acute Myeloid Patients Treated with Venetoclax and Azacitidine - ScienceDirect